Novartis markets its products worldwide under well-known brands such as Entresto, Cosentyx, Kesimpta, Kisqali, and Tasigna, among others
No refrigeration needed
As an observational study relying on self-reported weight data and medication order frequency as a proxy for adherence, the findings may be influenced by selection bias and unmeasured confounding
Elevated IGF-1 levels have been associated with increased risk of certain cancers, fluid retention, and joint pain
New insights in the targets of action of dimethyl fumarate in endothelial cells: effects on energetic metabolism and serine synthesis in vitro and in vivo
CVS Restores Coverage of Lillys Zepbound, Adds Oral Obesity Drug Foundayo Nicholas Jacobus Key Takeaways Zepbounds return as a preferred option reverses a prior formulary exclusion that maintained Wegovy coverage, underscoring how net pricing and rebate contracting drive PBM obesity access decisions